KNCV Tuberculosis Foundation - Your partner in the fight against TB
Accessed November 2017
In-and Out-Patient Treatment
The primary audience for this guideline includes health-care professionals who are responsible for developing national and local health-care protocols and policies, as well as managers of maternal and child health programmes and policy-makers in all settings. The guideline will also be useful to tho...se directly providing care to pregnant women and preterm infants, such as obstetricians, paediatricians, midwives, nurses and general practitioners. The information in this guideline will be useful for developing job aids and tools for pre- and in-service training of health workers to enhance their delivery of maternal and neonatal care relating to preterm birth.
more
European Union Standards for Tuberculosis Care 2017 Estonian Version
This leaflet is intended to inform physicians — mainly GPs — and medical students on how to recognize a possible radiation injury. It is important to note that radiation injury has no special signs and symptoms. However, the combination of some of them may be typical of radiation injury.
Arabic... version available: http://www.who.int/ionizing_radiation/pub_meet/en/Arabicleaflet.pdf?ua=1
more
This pocket guide is designed for clinicians, including physicians, nurses, and other health care professionals, who will provide emergency care following a radiological event. It should be used as a supplement to training and practice drills. (Prints on 8½" x 14" paper)
Facilitator's Guide
Refresher Training Module for Health Care Providers implementing the MISP
Inter-agency Working Group on Reproductive Health in Crises Training Partnership
WHO published guidance for clinicians and health care decision-makers on the use of corticosteroids in patients with COVID-19.
We recommend systemic corticosteroids for the treatment of patients with severe and critical COVID-19. We suggest not to use corticosteroids in the treatment of patients ...with non-severe COVID-19 as the treatment brought no benefits, and could even prove harmful. Treatment should be under supervision of a clinician.
Corticosteroids are listed in the WHO model list of essential medicines, readily available globally at a low cost. WHO encourages countries to maintain sufficient stocks of corticosteroids to treat COVID-19 and the other disease for which they are effective, while not maintaining excessive stocks which could deny other countries access.
more
This Quick Reference Handbook of Selected Congenital Anomalies and Infections is a companion tool to Birth defects surveillance: a manual for programme managers, and is intended for use by front-line health care professionals who are diagnosing and collecting data on congenital defects and infection...s. When used in conjunction with the manual, the tools in this handbook will help the reader to: identify an initial list of congenital anomalies to consider for monitoring;describe the tools needed to define and code identified cases; define specific congenital anomalies under surveillance.
more
The recommendation in this document thus supersedes the previous WHO recommendation for the prevention of PPH as published in the 2012 guideline, WHO recommendations for the prevention and treatment of postpartum haemorrhage.
Nota INformatIva Nº 13/2020 - SE/GaB/SE/mS
September 2020
This technical brief describes the re-affirmed WHO recommendation on ultrasound examination in the context of routine antenatal care and outlines policy and programme implications for translating this recommendation into action at the country level.